Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.
about
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Prevention of mother-to-child transmission of HIV: cost-effectiveness of antiretroviral regimens and feeding options in RwandaProvision of antiretroviral treatment in conflict settings: the experience of Médecins Sans FrontièresTwo-year morbidity-mortality and alternatives to prolonged breast-feeding among children born to HIV-infected mothers in Côte d'IvoireEffectiveness of non-nucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in women previously exposed to a single intrapartum dose of nevirapine: a multi-country, prospective cohort studyWHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothersAdherence to combination prophylaxis for prevention of mother-to-child-transmission of HIV in TanzaniaWhat will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysisHematological changes in women and infants exposed to an AZT-containing regimen for prevention of mother-to-child-transmission of HIV in TanzaniaPoint-of-care CD4 testing to inform selection of antiretroviral medications in south african antenatal clinics: a cost-effectiveness analysisDoes maternal HSV-2 coinfection increase mother-to-child transmission of HIV? A systematic review.Analysis of HIV early infant diagnosis data to estimate rates of perinatal HIV transmission in ZambiaHigh Rates of Exclusive Breastfeeding in Both Arms of a Peer Counseling Study Promoting EBF Among HIV-Infected Kenyan WomenImpact of nevirapine (NVP) plasma concentration on selection of resistant virus in mothers who received single-dose NVP to prevent perinatal human immunodeficiency virus type 1 transmission and persistence of resistant virus in their infected childrAntiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.When do HIV-infected women disclose their HIV status to their male partner and why? A study in a PMTCT programme, Abidjan.18-month effectiveness of short-course antiretroviral regimens combined with alternatives to breastfeeding to prevent HIV mother-to-child transmission.18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Côte d'Ivoire: a cohort study.Duration, pattern of breastfeeding and postnatal transmission of HIV: pooled analysis of individual data from West and South African cohortsThe contribution of family planning towards the prevention of vertical HIV transmission in Uganda.Effectiveness of multidrug antiretroviral regimens to prevent mother-to-child transmission of HIV-1 in routine public health services in Cameroon.Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding--the Kisumu Breastfeeding Study, Kenya: a clinical trial.Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity.Individualizing the WHO HIV and infant feeding guidelines: optimal breastfeeding duration to maximize infant HIV-free survivalEarly infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions.Impact of HIV/Aids on Child Mortality before the Highly Active Antiretroviral Therapy Era: A Study in Pointe-Noire, Republic of Congo.The study of HIV and antenatal care integration in pregnancy in Kenya: design, methods, and baseline results of a cluster-randomized controlled trialAntiretroviral treatment for children with peripartum nevirapine exposure.Prevention of mother to child transmission of human immunodeficiency virus: the nigerian perspectiveMother-to-child transmission of HIV and its predictors among HIV-exposed infants at a PMTCT clinic in northwest Ethiopia.Initial programmatic implementation of WHO option B in Botswana associated with increased projected MTCTProgress in the prevention of mother to child transmission of HIV in three regions of Tanzania: a retrospective analysis.What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needsViral sequence analysis from HIV-infected mothers and infants: molecular evolution, diversity, and risk factors for mother-to-child transmission.Current status of medication adherence and infant follow up in the prevention of mother to child HIV transmission programme in Addis Ababa: a cohort studyPharmacologic and nonpharmacologic options for the management of HIV infection during pregnancy.Comparison of anti-retroviral therapy treatment strategies in prevention of mother-to-child transmission in a teaching hospital in EthiopiaA cross-sectional study of the magnitude, barriers, and outcomes of HIV status disclosure among women participating in a perinatal HIV transmission study, "the Nevirapine Repeat Pregnancy study".Prenatal Transmission of Syphilis and Human Immunodeficiency Virus in Brazil: Achieving Regional Targets for EliminationUniversal antiretroviral therapy for pregnant and breast-feeding HIV-1-infected women: towards the elimination of mother-to-child transmission of HIV-1 in resource-limited settings.
P2860
Q21034169-15408780-26AC-4F66-B195-A0AD05825BB1Q21034187-DB0FC717-7400-40C8-86EF-77F008733EACQ21202765-A7637719-F409-42F4-8A8F-EC9355F1DE07Q28469112-7325FF7D-04D0-4B2D-B99C-55288CB84185Q28472889-6C86DF02-8A5B-4CA1-8E66-4D54586BB883Q28478406-EA5ED115-7E25-489E-919E-C93AB85275C7Q28478531-E4192DCA-187D-4726-9BA7-847EADE0EE29Q28478769-B8E91458-69C3-47F7-AA59-BC1C3414A0FBQ28485996-65DFD5C3-2AFB-4178-BF3C-FA4009CB7ECFQ28543954-ADA5ADCB-B3DA-4443-96DD-6E01119B64CBQ30402908-BF005630-61F8-4681-9E99-E7D55882F401Q30558708-ED864D2C-2DDF-4000-8C57-1BA6D60F67A7Q30724659-397B4B6D-038D-43EA-ABB3-061FCEE40A04Q33267065-B43ED191-7636-43BB-8720-93FB00CA5969Q33294899-074C0828-1E94-4CB1-89A7-23C884EF6E52Q33308259-52E11B3B-A487-4F71-8454-81019C41C54BQ33320539-15065034-B296-4B22-9523-021ABD7F6B5FQ33336235-EC8C9BC2-291B-48A9-BABE-0C8CCC520A29Q33510928-415678B6-6666-4BA2-926A-A92B12D33161Q33514838-BCFBBD61-6029-472D-846B-D5A0DEE267ABQ33818426-85216738-61B1-4BAF-A56D-0775828343F6Q33863552-60D7187E-1DD0-4715-8CBA-6BDBF5D76A34Q33897042-D29DC267-56BB-4159-AACF-F041ABE8E09DQ33902803-F4D8FF4F-8240-42D8-B6F8-D75B7752EE69Q33907111-7488B160-8940-40D6-A7C9-8DF25EE2DBCAQ34106178-13CD9D5F-9FBA-44C2-A6CE-19B7ADFF6964Q34412260-46C264F7-0759-4826-9EF0-9EAB33704C70Q34494986-DFEC4B76-C477-45F8-A288-C97994DB8C65Q34500949-45C2FF11-C731-45C6-B7BB-9D8AB540D28DQ34690285-3D6CFF8D-3CDC-420D-AA91-D98143E786E8Q35079468-2655B3D7-7787-4BF8-ABD7-E0BD5E31F108Q35097481-DEB07A43-91B8-4301-BA92-88692C4E6DA6Q35215012-BED21A4F-F5CE-44B6-9F58-29B0DABD95B3Q35219574-77C07679-513A-40BE-A7D2-5733416DCDA4Q35545908-75B7EAA5-E154-46B9-A271-04D142EDF4C7Q35557216-27DCC30B-A12B-4630-94AF-5D50086A1727Q35788526-86AA83A3-E0DD-4193-936C-9266EB05583DQ35792581-6AF82BF1-80A1-47BA-8778-20E38777B8B7Q35837696-8D83BE3E-B44A-4A0F-A0F8-39D56A446849Q35842613-07E20D90-B193-4CEA-84CB-98F76564B880
P2860
Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Field efficacy of zidovudine, ...... t peripartum HIV transmission.
@ast
Field efficacy of zidovudine, ...... t peripartum HIV transmission.
@en
type
label
Field efficacy of zidovudine, ...... t peripartum HIV transmission.
@ast
Field efficacy of zidovudine, ...... t peripartum HIV transmission.
@en
prefLabel
Field efficacy of zidovudine, ...... t peripartum HIV transmission.
@ast
Field efficacy of zidovudine, ...... t peripartum HIV transmission.
@en
P2093
P2860
P1433
P1476
Field efficacy of zidovudine, ...... t peripartum HIV transmission.
@en
P2093
ANRS 1201/1202 DITRAME PLUS Study Group
Apollinaire Horo
Charlotte Sakarovitch
Chrisitine Rouzioux
Christiane Welffens-Ekra
Didier Koumavi Ekouevi
François Rouet
Laurence Bequet
Laurence Dequae-Merchadou
P2860
P304
P407
P577
2005-02-01T00:00:00Z